Pharmanutra
Develops science-backed nutraceuticals & pharmaceuticals for nutritional & joint health.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PharmaNutra S.p.A., established in 2003, is an Italian company specializing in the research, development, and marketing of nutraceutical products, food supplements, and medical devices. The company focuses on creating innovative and scientifically-backed solutions, particularly for nutritional deficiencies in minerals and vitamins, as well as for muscle and joint health. PharmaNutra manages the entire production cycle, from proprietary raw materials to the finished product, ensuring high standards of efficacy and safety. The group also develops and sells pharmaceuticals, distinguishing itself through a strong emphasis on scientific research and innovation.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Pharmanutra and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-12 10:35 |
Interim Report
Half Year Financial Report 2025
|
English | 3.3 MB | |
| 2025-09-12 10:34 |
Interim Report
Relazione finanziaria semestrale 2025
|
Italian | 3.4 MB | |
| 2025-09-12 10:33 |
Report Publication Announcement
CS_Disponibilità Relazione Semestrale 2025 || Availability Half Year financial …
|
Italian | 269.4 KB | |
| 2025-09-08 17:55 |
Earnings Release
PHN: The Board of Directors approved the results as of 30 June 2025
|
English | 443.8 KB | |
| 2025-09-08 17:55 |
Earnings Release
PHN: il Consiglio di Amministrazione ha approvato i risultati al 30 giugno 2025
|
Italian | 370.0 KB | |
| 2025-08-04 18:05 |
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
|
English | 465.8 KB | |
| 2025-08-04 18:04 |
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
|
Italian | 259.1 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
|
Italian | 189.4 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
|
English | 241.0 KB | |
| 2025-05-27 10:47 |
Investor Presentation
MIDCAP Road Show - Paris
|
English | 3.4 MB | |
| 2025-05-15 15:26 |
Registration Form
Statuto sociale aggiornato
|
Italian | 295.1 KB | |
| 2025-05-15 15:25 |
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
|
Italian | 9.4 MB | |
| 2025-05-15 15:23 |
Post-Annual General Meeting Information
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
|
Italian | 172.3 KB | |
| 2025-05-14 11:46 |
Quarterly Report
Interim Management report as at March 31st, 2025
|
English | 1.7 MB | |
| 2025-05-14 11:45 |
Management Discussion and Analysis
Resoconto Intermedio di gestione al 31 Marzo 2025
|
Italian | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
